早产儿ECMO应用的可行性和临床实施方案OA
Feasibility of ECMO application in preterm infants and clinical implementation protocol
体外膜肺氧合(extracorporeal membrane oxygenation,ECMO)作为挽救危重新生儿生命的核心技术,在足月新生儿严重呼吸循环衰竭治疗中已趋于成熟,但早产儿群体因生理脆弱性等特点,其应用长期受限.本文系统梳理了早产儿ECMO应用的历史演变、可行性、核心挑战、关键技术要点、预后结局及伦理考量,聚焦临床循证依据与实践核心,为该技术的规范应用提供科学参考.
Extracorporeal membrane oxygenation(ECMO),as a core technology for saving the lives of critically ill neonates,has become mature in the treatment of severe cardiopulmonary failure in term neonates.However,its application in preterm infants has long been restricted due to their physiological fragility and other characteristics.This article systematically sorts out the historical evolution,feasibility,core challenges,key technical points,prognostic outcomes,and ethical considerations of ECMO application in preterm infants,focusing on clinical evidence-based basis and practical core,so as to provide scientific reference for the standardized application of this technology.
李秋平;曹婧可;洪小杨;赵喆;王刚;封志纯;中国儿科体外生命支持联盟
解放军总医院第七医学中心 儿科医学部NICU,北京 100700南方医科大学 第二临床医学院,广东 广州 510515解放军总医院第七医学中心 儿科医学部PICU,北京 100700解放军总医院第七医学中心 儿科医学部PICU,北京 100700解放军总医院第七医学中心 儿科医学部儿童心外科,北京 100700解放军总医院第七医学中心 儿科医学部出生缺陷防控国家工程实验室,北京 100700
早产儿体外膜肺氧合可行性关键技术预后伦理考量
Preterm infantExtracorporeal membrane oxygenationFeasibilityKey technologyPrognosisEthical considerations
《发育医学电子杂志》 2026 (2)
81-88,8
国家重点研发计划(2021YFC2701700,2021YFC2701702)
评论